The recent acquisition of Mission Cancer + Blood by University of Iowa Health Care (UI Health) has sparked a heated debate over rising healthcare costs in Iowa. The deal, valued at $280 million, was touted as a way to enhance cancer care, especially in rural areas, where Iowa has the second-highest cancer rate in the country. However, the reality for many patients is a stark contrast to this promise. Since the acquisition, patients have been facing significantly higher charges for routine clinic services, with some bills skyrocketing from the hundreds to thousands of dollars. This has raised concerns about the accessibility and affordability of cancer care, particularly for those already struggling with high premiums, stagnant wages, and inflation. The issue is not isolated to Mission Cancer + Blood; it is a trend seen across large hospital systems acquiring independent clinics. The higher charges are often due to the inclusion of hospital facility fees, which cover staffing, equipment, and overhead. This has prompted several states to ban these fees for specified procedures or care settings. In Iowa, the situation is particularly troubling, as UI Health is a tax-exempt state institution with a mission to serve through clinical care, education, and research, not to generate profit. The sudden increase in charges has caused frustration among patients, many of whom have been told to undergo routine tests and visits for peace of mind. The author, who received a bill of $1,991 for a routine visit and blood test, highlights the financial burden this places on individuals and families already grappling with rising healthcare costs. The situation is further complicated by the fact that many patients were not adequately informed about the change in billing practices. The author questions the role of the Iowa Board of Regents and the Iowa Senate in addressing the affordability of cancer care and limiting hospital rates for outpatient care. The article concludes by emphasizing the importance of ensuring that promises of better care are not empty, and that healthcare remains accessible and affordable for all, especially in the face of rising costs and consolidation in the healthcare industry.
